Detalhe da pesquisa
1.
Heterogeneity and transcriptional drivers of triple-negative breast cancer.
Cell Rep;
42(12): 113564, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100350
2.
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.
Cancer Res;
83(19): 3284-3304, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450351
3.
Assessment of spatial transcriptomics for oncology discovery.
Cell Rep Methods;
2(11): 100340, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36452860
4.
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer.
Cancer Res;
82(20): 3673-3686, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35950920
5.
Predicting master transcription factors from pan-cancer expression data.
Sci Adv;
7(48): eabf6123, 2021 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818047
6.
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.
Nat Cell Biol;
23(11): 1187-1198, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34737445
7.
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Nat Commun;
12(1): 5775, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599169
8.
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.
Nat Cancer;
2(1): 34-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33997789
9.
A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.
Cancer Cell;
39(3): 380-393.e8, 2021 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33689703
10.
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade.
Cancer Discov;
11(6): 1524-1541, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589424
11.
ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer.
Cancer Res;
80(21): 4612-4619, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32934023
12.
Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Nat Genet;
52(8): 790-799, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32690948
13.
FiTAc-seq: fixed-tissue ChIP-seq for H3K27ac profiling and super-enhancer analysis of FFPE tissues.
Nat Protoc;
15(8): 2503-2518, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591768
14.
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.
Mol Cell;
78(6): 1096-1113.e8, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416067
15.
Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers.
iScience;
21: 341-358, 2019 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31698248
16.
Publisher Correction: Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
Nat Med;
25(10): 1627, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501535
17.
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
Nat Med;
25(8): 1260-1265, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263286
18.
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.
Oncotarget;
8(43): 74106-74118, 2017 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29088771
19.
Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
Cell Rep;
18(10): 2359-2372, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273452
20.
FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
Hum Pathol;
62: 222-231, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28087474